Shares of Argent BioPharma Limited (LON:MXC – Get Free Report) traded up 4.8% during trading on Wednesday . The company traded as high as GBX 22 ($0.28) and last traded at GBX 22 ($0.28). 264 shares changed hands during trading, a decline of 99% from the average session volume of 26,353 shares. The stock had previously closed at GBX 21 ($0.27).
Argent BioPharma Stock Up 4.8 %
The stock has a market capitalization of £9.65 million, a price-to-earnings ratio of -13.25 and a beta of 1.03. The stock has a 50 day moving average price of GBX 21.22 and a 200 day moving average price of GBX 21.53.
About Argent BioPharma
MGC Pharmaceuticals Limited provides phytomedicines worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia.
See Also
- Five stocks we like better than Argent BioPharma
- How to Calculate Options Profits
- AbbVie Stock: A Perfect Dip for Investors to Buy
- High Flyers: 3 Natural Gas Stocks for March 2022
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- What is a buyback in stocks? A comprehensive guide for investors
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Argent BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Argent BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
